共 50 条
- [31] Total costs of therapy with lenalidomide or bortezomib in relapsed/refractory multiple myeloma (rrMM).[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Borrello, Ivan论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Baltimore, MD USABinder, Gary论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Baltimore, MD USAKhan, Zeba M.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Baltimore, MD USAPashos, Chris L.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Baltimore, MD USADurie, Brian G.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Baltimore, MD USA
- [32] A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma[J]. BLOOD, 2014, 123 (10) : 1461 - 1469Richardson, Paul G.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAXie, Wanling论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAJagannath, Sundar论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Med Ctr, Tisch Canc Inst, New York, NY 10029 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAJakubowiak, Andrzej论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USALonial, Sagar论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USARaje, Noopur S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Multiple Myeloma, Boston, MA 02114 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAAlsina, Melissa论文数: 0 引用数: 0 h-index: 0机构: Univ S Florida, H Lee Moffitt Canc Ctr, Dept Blood & Marrow Transplantat, Tampa, FL 33682 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAGhobrial, Irene M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USASchlossman, Robert L.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMunshi, Nikhil C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMazumder, Amitabha论文数: 0 引用数: 0 h-index: 0机构: NYU, Dept Med, Ctr Comprehens Canc, New York, NY 10016 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAVesole, David H.论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Multiple Myeloma Div, Hackensack, NJ USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAColson, Kathleen论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMcKenney, Mary论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USALunde, Laura E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAFeather, John论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMaglio, Michelle E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAWarren, Diane论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAFrancis, Dixil论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAHideshima, Teru论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAKnight, Robert论文数: 0 引用数: 0 h-index: 0机构: Celgene Inc, Oncol Res & Dev, Summit, NJ USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAEsseltine, Dixie-Lee论文数: 0 引用数: 0 h-index: 0机构: Millennium, Oncol Clin Res, Cambridge, MA USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMitsiades, Constantine S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAWeller, Edie论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAAnderson, Kenneth C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
- [33] Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients[J]. ACTA ONCOLOGICA, 2000, 39 (07) : 809 - 813Wisloff, F论文数: 0 引用数: 0 h-index: 0机构: Ulleval Univ Hosp, Dept Hematol, N-0407 Oslo, Norway Ulleval Univ Hosp, Dept Hematol, N-0407 Oslo, NorwayGulbrandsen, N论文数: 0 引用数: 0 h-index: 0机构: Ulleval Univ Hosp, Dept Hematol, N-0407 Oslo, Norway Ulleval Univ Hosp, Dept Hematol, N-0407 Oslo, Norway
- [34] Bortezomib in Relapsed/Refractory Multiple Myeloma[J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62Shen, Z.论文数: 0 引用数: 0 h-index: 0机构: Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R China Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R ChinaWang, L.论文数: 0 引用数: 0 h-index: 0机构: Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R China Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R ChinaYan, H.论文数: 0 引用数: 0 h-index: 0机构: Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R China Rui Jin Hosp, Shanghai Inst Hematol, Dept Hematol, Shanghai, Peoples R China
- [35] Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone: Patient Reported Outcomes from GRIFFIN[J]. BLOOD, 2022, 140 : 1146 - 1149论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Kaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USASborov, Douglas W.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAReeves, Brandi论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Chapel Hill, NC USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USARodriguez, Cesar论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USACosta, Luciano J.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama, Birmingham Hosp, Vestavia, AL USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAAnderson, Larry D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Southwestern Med Ctr Dallas, Div Hematol & Oncol, Dallas, TX USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USANathwani, Nitya论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Duarte, CA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAShah, Nina论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USABumma, Naresh论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol, Comprehens Canc Ctr, Columbus, OH USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAHolstein, Sarah A.论文数: 0 引用数: 0 h-index: 0机构: Univ Nebraska Med Ctr, Div Oncol & Hematol, Omaha, NE USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USACostello, Caitlin论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAJakubowiak, Andrzej论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAOrlowski, Robert Z.论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAShain, Kenneth H.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USACowan, Andrew J.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Div Med Oncol, Seattle, WA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAGries, Katharine S.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAPei, Huiling论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Titusville, NJ USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USACortoos, Annelore论文数: 0 引用数: 0 h-index: 0机构: Janssen Sci Affairs LLC, Horsham, PA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAPatel, Sharmila论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USALin, Thomas S.论文数: 0 引用数: 0 h-index: 0机构: Janssen Sci Affairs LLC, Horsham, PA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USARichardson, Paul G.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAUsmani, Saad论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth Wake Forest Baptist, Levine Canc Inst, Charlotte, NC USA Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
- [36] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90Shin, Junghoon论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Je-Jung论文数: 0 引用数: 0 h-index: 0机构: Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Kihyun论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Dept Internal Med, Samsung Med Ctr, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaMin, Chang-Ki论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Dept Internal Med, Seoul St Marys Hosp, Div Hematol,Coll Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Jeong-Ok论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea论文数: 引用数: h-index:机构:Kim, Jin Seok论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea论文数: 引用数: h-index:机构:Yoon, Sung-Soo论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaJo, Jae-Cheol论文数: 0 引用数: 0 h-index: 0机构: Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Ho Sup论文数: 0 引用数: 0 h-index: 0机构: Kosin Univ, Dept Internal Med, Coll Med, Busan, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaBang, Soo-Mee论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Jeong-Ok论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaBang, Soo-Mee论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Je-Jung论文数: 0 引用数: 0 h-index: 0机构: Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Kihyun论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Dept Internal Med, Samsung Med Ctr, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaMin, Chang-Ki论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Dept Internal Med, Seoul St Marys Hosp, Div Hematol,Coll Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea论文数: 引用数: h-index:机构:Yoon, Dok Hyun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Jin Seok论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea论文数: 引用数: h-index:机构:Moon, Joon Ho论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaYoon, Sung-Soo论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Inho论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaJo, Jae-Cheol论文数: 0 引用数: 0 h-index: 0机构: Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Ho Sup论文数: 0 引用数: 0 h-index: 0机构: Kosin Univ, Dept Internal Med, Coll Med, Busan, South Korea Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaPark, Seong Kyu论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaShin, Ho-Jin论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Min Kyoung论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaMun, Yeung-Chul论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Mark Hong论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaPark, Yong论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaEom, Hyeon Seok论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Hyo Jung论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaIm, Sung Nam论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaKim, Sung-Hyun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaDo, Young Rok论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Won Sik论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaCho, Su-Hee论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaYi, Jun Ho论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South KoreaLee, Jae Hoon论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematol Oncol, 82,Gumi Ro 173 Beon Gil, Songnam 13620, South Korea
- [37] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone[J]. International Journal of Hematology, 2019, 109 : 79 - 90Junghoon Shin论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyJe-Jung Lee论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyKihyun Kim论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyChang-Ki Min论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyJeong-Ok Lee论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyCheolwon Suh论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyJin Seok Kim论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyYoo Jin Lee论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologySung-Soo Yoon论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyJae-Cheol Jo论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologyHo Sup Lee论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of HematologySoo-Mee Bang论文数: 0 引用数: 0 h-index: 0机构: Seoul National University Bundang Hospital,Division of Hematology
- [38] A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide[J]. BLOOD, 2012, 119 (12) : 2764 - 2767Dimopoulos, Meletios A.论文数: 0 引用数: 0 h-index: 0机构: Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, Greece Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceRichardson, Paul G.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceBrandenburg, Nancy论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceYu, Zhinuan论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceWeber, Donna M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceNiesvizky, Ruben论文数: 0 引用数: 0 h-index: 0机构: Cornell Univ, Weill Med Coll, New York, NY 10021 USA Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, GreeceMorgan, Gareth J.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, London SW3 6JJ, England Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, Greece
- [39] Our Experience of Using Lenalidomide, Bortezomib and Dexamethasone (RVD) Therapy in Patients with Relapsed/Refractory Multiple Myeloma[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S340 - S341Pogosyan, Gayane论文数: 0 引用数: 0 h-index: 0机构: Fed Almazov Med Res Ctr, Dept Hematol, St Petersburg, Russia Fed Almazov Med Res Ctr, Dept Hematol, St Petersburg, Russia
- [40] Incidence of secondary cancers in refractory or relapsed multiple myeloma treated with lenalidomide[J]. HEMATOLOGIE, 2012, 18 (03): : 150 - 151Guidez, Stephanie论文数: 0 引用数: 0 h-index: 0Leleu, Xavier论文数: 0 引用数: 0 h-index: 0